SCHEMBL30486807

SCHEMBL30486807

CN1CCC(C(=O)Nc2ccccc2F)C1=O

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ MAPT P10636 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ TSHR P16473 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ EPHX2 P34913 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ PKM P14618 1/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30486811 1.00 KMT2A (0.53) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL21662059 1.00 KMT2A (0.53) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL22337503 0.90 TP53 (0.51) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL30486800 0.90 TP53 (0.51) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL22337322 0.90 TP53 (0.51) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL22337481 0.85 P2RX7 (0.43) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL22309591 0.85 TYK2 (0.46) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL22337500 0.85 P2RX7 (0.43) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL25633256 0.85 L3MBTL1 (0.49) KMT2AMEN1MAPTSMN1; SMN2TSHR
SCHEMBL22337310 0.84 MEN1 (0.39) KMT2AMEN1MAPTSMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022095-A1 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF ADAMA AGAN LTD. (IL) 2026-01-22 — — US disclosed
US-20250197350-A1 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF ADAMA AGAN LTD. (IL) 2025-06-19 — — US disclosed
US-20250066297-A1 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF ADAMA AGAN LTD. (IL) 2025-02-27 — — US disclosed
EP-4508980-A2 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF Adama Agan Ltd. (IL) 2025-02-19 — — EP disclosed
EP-4483714-A2 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF Adama Agan Ltd. (IL) 2025-01-01 — — EP disclosed
EP-4447681-A2 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF Adama Agan Ltd. (IL) 2024-10-23 — — EP disclosed
CN-118401112-A Compounds for preparing various agrochemicals and markers thereof 安道麦阿甘有限公司 2024-07-26 — — CN disclosed
WO-2023112033-A2 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF ADAMA AGAN LTD. (IL) 2023-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022095-A1 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF TET1, FOXK1, TET3 KMT2A 340/4885MEN1 4270/4885MAPT 1617/4885
US-20250197350-A1 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF GYS2, PFAS, CD68 KMT2A 3181/4885MEN1 4369/4885MAPT 423/4885
US-20250066297-A1 COMPOUNDS USEFUL FOR THE PREPARATION OF VARIOUS AGROCHEMICALS AND MARKERS THEREOF GYS2, PFAS, CD68 KMT2A 3181/4885MEN1 4369/4885MAPT 423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback